Patent Assignment
Reel/Frame 059013/0205
Assignment of Assignor's Interest
Recorded: 2022-02-15
Pages: 3
Assignee
NOVOCURE GMBH
6 PARK, ROOT D4, 6039, SWITZERLAND
Covered Properties
(3)
Treating Tumors with TTFields and an Aurora Kinase Inhibitor
Treating Tumors Using Ttfields Combined with a Kinase Inhibitor
Application:
62/654,679 →
Treating Tumors with TTFields and an Aurora Kinase Inhibitor
Application:
62/826,114 →
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
Assignment of Assignor's Interest
Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
Omnibus Confirmation of Assignment Agreement
May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
Release of Security Interest for Patent Security Agreement Filed at Reel/Frame 50395/0398
Aug 19, 2020
From: BPCR LIMITED PARTNERSHIP
To: NOVOCURE GMBH
Reel/Frame 053538/0623 →
Security Interest
Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
Assignment of Assignor's Interest
Feb 15, 2022
From: SHNAIDERMAN, ROSA; GILADI, MOSHE
To: NOVOCURE LIMITED
Reel/Frame 059013/0240 →
Assignment of Assignor's Interest
Feb 15, 2022
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 059013/0312 →
Release of Security Interest
Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
Patent Security Agreement
May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →